Clinical Trials Directory

Trials / Completed

CompletedNCT03034928

Clinical Biocompatibility Evaluation of Contact Lens Coatings

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to evaluate corneal staining observed after 2 hours of wear with contact lenses with investigational coating against PureVision™ lenses, all pre-cycled with OPTI-FREE® RepleniSH® multi-purpose disinfection solution.

Detailed description

In this contralateral crossover study, qualifying subjects will wear a total of 2 pairs of study contact lenses. Lenses will be worn according to a randomized lens sequence assignment. Each pair will consist of a test lens (Test 1 or Test 2) and a control lens.

Conditions

Interventions

TypeNameDescription
DEVICEContact lens with investigational coating 1Contact lens with investigational coating 1 pre-cycled in OPTI-FREE® RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)
DEVICEBalafilcon A contact lensBalafilcon A contact lens pre-cycled OPTI-FREE® RepleniSH® MPDS
DEVICEOPTI-FREE® RepleniSH® MPDSMultipurpose contact lens solution
DEVICEContact lens with investigational coating 2Contact lens with investigational coating 2 pre-cycled in OPTI-FREE® RepleniSH® MPDS

Timeline

Start date
2017-02-14
Primary completion
2017-03-14
Completion
2017-03-14
First posted
2017-01-27
Last updated
2020-02-18
Results posted
2020-02-18

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03034928. Inclusion in this directory is not an endorsement.

Clinical Biocompatibility Evaluation of Contact Lens Coatings (NCT03034928) · Clinical Trials Directory